22-36933957-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000395.3(CSF2RB):c.1278C>T(p.Ser426=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 1,612,486 control chromosomes in the GnomAD database, including 39,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3444 hom., cov: 31)
Exomes 𝑓: 0.22 ( 36338 hom. )
Consequence
CSF2RB
NM_000395.3 synonymous
NM_000395.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.990
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 22-36933957-C-T is Benign according to our data. Variant chr22-36933957-C-T is described in ClinVar as [Benign]. Clinvar id is 226545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36933957-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.1278C>T | p.Ser426= | synonymous_variant | 10/14 | ENST00000403662.8 | NP_000386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.1278C>T | p.Ser426= | synonymous_variant | 10/14 | 5 | NM_000395.3 | ENSP00000384053 | P1 | |
CSF2RB | ENST00000406230.5 | c.1296C>T | p.Ser432= | synonymous_variant | 9/13 | 1 | ENSP00000385271 |
Frequencies
GnomAD3 genomes AF: 0.207 AC: 31404AN: 151816Hom.: 3444 Cov.: 31
GnomAD3 genomes
AF:
AC:
31404
AN:
151816
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.189 AC: 47091AN: 249068Hom.: 5078 AF XY: 0.195 AC XY: 26277AN XY: 134914
GnomAD3 exomes
AF:
AC:
47091
AN:
249068
Hom.:
AF XY:
AC XY:
26277
AN XY:
134914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.218 AC: 318672AN: 1460552Hom.: 36338 Cov.: 38 AF XY: 0.219 AC XY: 159139AN XY: 726608
GnomAD4 exome
AF:
AC:
318672
AN:
1460552
Hom.:
Cov.:
38
AF XY:
AC XY:
159139
AN XY:
726608
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.207 AC: 31407AN: 151934Hom.: 3444 Cov.: 31 AF XY: 0.199 AC XY: 14796AN XY: 74268
GnomAD4 genome
AF:
AC:
31407
AN:
151934
Hom.:
Cov.:
31
AF XY:
AC XY:
14796
AN XY:
74268
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
439
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Ser426Ser in exon 10 of CSF2RB: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 23.6% (1042/4406) of African American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs1801117). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 37
Find out detailed SpliceAI scores and Pangolin per-transcript scores at